Echocardiography-based machine learning algorithm for distinguishing ischemic cardiomyopathy from dilated

Mei Zhou1, Yongjian Deng1, Yi Liu1

  • 1Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, 6 Shuangyong Road, Nanning, 530021, Guangxi, China.

BMC Cardiovascular Disorders
|September 26, 2023
PubMed

Insights

Machine learning effectively differentiates ischemic cardiomyopathy from dilated cardiomyopathy using echocardiographic data. This aids in precise etiological diagnosis and personalized heart failure treatment.

Area of Science:

  • Cardiology
  • Medical Informatics
  • Machine Learning

Background:

  • Heart failure is often caused by cardiomyopathy, necessitating distinct treatments based on etiology.
  • Differentiating between ischemic cardiomyopathy (ICM) and dilated cardiomyopathy (DCM) is crucial for effective patient management.
  • Machine learning (ML) offers potential for analyzing complex data to predict and diagnose cardiovascular conditions.

Purpose of the Study:

  • To evaluate the diagnostic performance of an ML algorithm in distinguishing ICM from DCM.
  • To assess the utility of combining echocardiographic data for automated cardiomyopathy classification.
  • To explore the potential of ML in improving etiological diagnosis for heart failure.

Main Methods:

  • Retrospective collection of echocardiographic data from 200 DCM and 199 ICM patients.
  • Data split into training and test sets using 10-fold cross-validation.
  • Comparison of four ML algorithms (random forest, logistic regression, neural network, XGBoost) for classification accuracy.

Main Results:

  • The XGBoost model achieved the highest diagnostic performance with an AUC of 0.934.
  • XGBoost demonstrated an average sensitivity of 72% and specificity of 78% on the test set.
  • External validation showed an AUC of 0.804, indicating generalizability.

Conclusions:

  • Advanced ML algorithms can accurately differentiate ICM from DCM using echocardiographic parameters.
  • This approach offers precision in etiological diagnosis for heart failure.
  • ML-driven insights can support individualized treatment strategies for cardiomyopathy patients.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System I:Echocardiography01:17

Imaging Studies for Cardiovascular System I:Echocardiography

Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
359
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
15
Imaging Studies for Cardiovascular System II:Types of Echocardiography01:20

Imaging Studies for Cardiovascular System II:Types of Echocardiography

Echocardiography plays a role in assessing cardiac health and detecting heart conditions, with various types providing critical insights for diagnosis and treatment.
Types of Echocardiography
Transthoracic Echocardiography (TTE)
TTE is the most common type of echocardiogram which involves placing a transducer on the patient's chest, emitting sound waves to create heart images. TTE is invaluable for evaluating the heart's size, structure, and motion, making it particularly useful for...
291
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16